Hemodynamic effects of arbutamine

American Journal of Cardiology

Volumn 82, Issue 5, 1998, Pages 699-702

  Ogilby, J David ^b   Molk, Barry ^b   Iskandrian, Ami E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BLOOD PRESSURE; CHRONOTROPISM; CORONARY ARTERY DISEASE; DRUG MECHANISM; HEART CATHETERIZATION; HEART INDEX; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HUMAN; INOTROPISM; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT; SYSTEMIC VASCULAR RESISTANCE;

ADULT; ANGINA PECTORIS; CARDIOTONIC AGENTS; CATECHOLAMINES; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INFUSION PUMPS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031679220     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00386-5     Document Type: Article

References (22)

1. Sonneblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new synthetic cardioactive sympathic amine. N Engl J Med 1979;300:17-22.
2. Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in consciour dogs. J Clin Invest 1974;53:1265-1273.
3. Abou-Mohamed G, Nagarajan R, Ibrahim TM. Characterization of the adrenergic activity of arbutamine: a novel agent for pharmacologic stress testing. Cardiovasc Drugs Ther 1996;10:39-47.
4. Kiat H, Iskandrian AS, Villegas BJ, Starling MR, Berman DS, and the International Arbutamine Study Group. Arbutamine stress thallium-201 SPECT using a computerized closed-loop delivery system: a multicenter trial for evaluation of safety and diagnostic accuracy. J Am Coll Cardiol 1995;26:1159-1167.
5. Cohen JL, Chan KL, Jaarsma W, Bach DS, Mutler DWM, Starling MR, Armstrong WFL. Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary disease. J Am Coll Cardiol 1995;26:1168-1175.
6. Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol 1990;16:1375-1383.
7. Gioia G, Bagheri B, Gottlieb CD, Schwartzman DS, Callans DJ, Marchlinski F, Heo J, Iskandrian AE. Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging. Circulation 1997;95:390-394.
8. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise levels on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477-1486.
9. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Waserleben V, Cave V. Independent and incremental prognostic value of exercise single photon emission commuted tomography (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-670.
10. Hammond HK, McKirnan MD. Effects of dobutamine and arbutamine on regional myocardial functions in a porcine model of myocardial ischemia. J Am Coll Cardiol 1994;23:475-482.
11. Ruffolo RR Jr. The mechanism of action of dobutamine. Ann Intern Med 1984;100:313-314.
12. Colucci WS, Leatherman GF, Ludmer PL, Gauthier DF. B-Adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion. Cir Res 1987;61(suppl I):182-186.
13. Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 1986;73(suppl III):175-183.
14. Mahmarian JJ, Verani MS. Myocardial perfusion imaging during pharmacologic stress testing. Cardiol Clin 1994;12:223-245.
15. Marwick T, D'Hondt AM, Baudhuin T, Willemant B, Wigns W, Detry JM, Melin S. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-167.
16. Pennell JD, Underwood SR, Swanton RH, Walker J, Ell PJ. Dobutamine thallium, myocardial perfusion tomography. J Am Coll Cardiol 1991;18:147-149.
17. Cohen JL, Ottenweller JE, George AK, Duvvuri S. Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease. Am J Cardiol 1993;72:1226-1231.
18. Hays JT, Mamharian JJ, Cochran A, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress test. J Am Coll Cardiol 1993;21:1583-1590.
19. Marwick T, Willemart B, D'Hondt AM, Baudhuin T, Wijns W, Detry JM, Melin J. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Circulation 1993;87:345-354.
20. Calnon DA, Glover DK, Beller GA, Vanzetto G, Watson DD, Ruia M. Effects of dobutamine stress on regional myocardial blood flow, technetium-99m sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses. Implications for pharmacologic stress testing. Circulation 1997;96:2353-2360.
21. Shehata AR, Ahberg AW, Gillam LD, Mascitelli VA, Piriz JM, Fleming RA, Chen C, Waters DD, Heller GV. Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography patients with coronary artery disease. Am J Cardiol 1997;80:716-720.
22. Soman P, Khattar R, Senior R, Lahiri A. Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography. J Nucl Card 1997;4:364-371.